Clinical trial · Interventional
Expressive Writing Program Among Young Adults With Blood Cancer
An Expressive Writing Program to Support Emotional Wellness Among Young Adults With Hematologic Malignancy
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this study is to learn more about an expressive writing workshop among people with blood cancer. The main question it aims to answer is whether and how an expressive writing workshop can impact mental wellness. Participants will * Take part in an online expressive writing workshop for four weeks * Take three surveys at different times over 12 weeks Researchers will compare changes in mental wellness reported by the participants of the workshop to those who will wait four weeks to start the workshop. After four weeks, the participants who are waiting will start their workshop.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hematologic Malignancy | Hematopoietic and Lymphoid Cell Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Expressive Writing Workshop | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Group 1
- description
- Primary Intervention Group
- interventionNames
- Behavioral: Expressive Writing Workshop
- type
- PLACEBO_COMPARATOR
- label
- Group 2
- description
- Wait List Control Group
- interventionNames
- Behavioral: Expressive Writing Workshop
Primary outcomes (2)
- measure
- Mental Wellbeing
- timeFrame
- Baseline, 4, and 8 weeks
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patient with a hematologic malignancy diagnosis in treatment or after treatment is completed, who is currently between the ages of 18 and 39 (young adult), or the informal caregiver of a young adult blood cancer patient * Located within the U.S., Canada, or U.S. territories * Able to read and write in English Exclusion Criteria: * Located outside of the U.S., Canada, or its territories * Participant is a minor aged 17 years or below
References
Publications (0)
Data not yet available